Accordingly, the present study provided convincing evidence that MMP‐2, as one MSC‐derived soluble factor, can modulate the pathogenic microenvironments of PD through proteolysis of aggregated α‐synuclein into soluble forms. Here, MMP2 is linked to Parkinson disease.